NewLink Genetics

About:

NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.

Website: http://www.newlinkgenetics.com

Twitter/X: nlnkgenetics

Top Investors: Ames Seed Capital, Chicagoland Investors, Midwest Oilseeds, Iowa Capital Management, NLG Advisors

Description:

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.

Total Funding Amount:

$33.6M

Headquarters Location:

Ames, Iowa, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)newlinkgenetics.com

Founders:

Charles Link, Nicholas Vahanian

Number of Employees:

51-100

Last Funding Date:

2009-07-21

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai